Osteopenia Unknown Status Phase 2 / 3 Trials for Alendronic acid (DB00630)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Unknown Status2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00209469Network Osteoporosis StudyTreatment